Early research (Phase 1)Study completedNCT02207790
What this trial is testing
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects
Who this might be right for
Healthy Subjects
Eisai Inc. 32